Subsidies for malaria treatment could save 25,000 lives a month

doi:10.1136/bmj.332.7541.569

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Janice Tanne

New York

Subsidies for combination treatments in countries where malaria is endemic are urgently needed to forestall drug resistance and save lives, warns a paper published this week.

A subsidy of only $100m (£57m; €83m) to $200m for artemisinin based combination drugs might be needed, said Ramanan Laxminarayan, from Resources for the Future, a non-profit, independent organisation based in Washington, DC, and the paper's lead author.

He said that if such a subsidy programme was implemented within three months, up to 25 000 lives a month could be saved (Health Affairs2006;25:325-36).

Dr Laxminarayan, whose …